In a recent pivot, Clarivate Plc (CLVT) was assigned an “Underweight” rating by Morgan Stanley analyst Toni Kaplan on December 17, 2025. The pronounced shift in outlook is significant for investors, as it suggests a cautious stance on the stock’s performance despite its current price of $3.54, aligning closely with a price target of $5. This development raises concerns regarding the company’s near-term prospects in a challenging market environment.
Market / Price Action
Shares of Clarivate Plc have been on a volatile trajectory, reflecting a market sentiment that appears apprehensive. Currently trading at $3.54, the stock has encountered a notable decline of approximately 0.7% in recent sessions, with a change of -0.025. Over the past year, CLVT has seen its value diminish significantly, with a remarkable high of $16.45 and a low of $3.54 over the 52-week period. The stock’s beta of 1.521 indicates that it is more volatile than the broader market, which has contributed to fluctuating investor sentiment. With a market capitalization of approximately $2.34 billion, the trading volume of 9,475,704 was well above the three-month average of 4,462,356, suggesting heightened interest, albeit possibly driven by speculative trading rather than strong fundamentals.
Short- and Long-Term Performance
Clarivate’s performance metrics uncover a mixed bag for potential investors. Over the last 30 days, the stock has rebounded modestly, showing a 5.04% increase, likely due to short-term trading fluctuations rather than any substantial corporate news. In contrast, the stock has struggled in the longer term, reflecting a -13.87% decline over the past 90 days and a stark -33.08% drop in the past year. Such performance should be contextualized within a broader market that has been navigating economic challenges and uncertainties, particularly in the technology and information services sector. Weekly volatility has been measured at 4.49, with monthly volatility slightly lower at 4.35, indicating varying degrees of investor concern over Clarivate’s outlook.
Earnings / Financials
The recent earnings report for Clarivate did not paint a favorable picture. For the period ending October 29, 2025, the company reported an earnings per share (EPS) of -$0.04235, which falls woefully short of the consensus estimate of $0.16, representing a staggering surprise factor of -126.47%. This stark miss follows a previous quarter where the EPS aligned with estimates, coming in at $0.18. Such an earnings surprise highlights both the unpredictability of Clarivate’s financial performance and raises questions about its operational efficiency and strategic direction.
Analyst / Consensus View
The consensus rating for Clarivate shows a decidedly negative shift, as indicated by the solo analysis from Morgan Stanley, which gives the stock an “Underweight” designation. With only one analyst rating to consider, there are currently no buy or hold recommendations, underscoring a cautious sentiment amongst professionals. The average price target remains at $5, which does present some potential upside from the current trading price, but this is tempered by the lack of confidence among analysts regarding the company’s future performance.
Stock Grading or Fundamental View
Clarivate’s Stocks Telegraph Score stands at 37, indicating a concerning investment profile when viewed through various financial health markers. A lower score suggests that investors should approach this stock with caution, as it may reflect weaknesses in its business model or market positioning.
Conclusion
For investors considering Clarivate Plc, this stock currently appears to suit a defensive strategy, given the significant downgrades and poor earnings outlook. The present share price of $3.54 may indicate limited upside potential against a backdrop of a $5 price target, although substantial risks persist. The negative consensus from analysts and the disappointing financial performance suggest that Clarivate is a candidate for those willing to tolerate higher levels of volatility and risk in exchange for a speculative bet. All eyes will remain on upcoming earnings reports and market movements, as these could further define the investment narrative for this beleaguered stock.